Public signal · 1-minute delayed

Signal brief

Source-backed market context you can read and share without an account.

High materiality9/10

Fortitude Q2 results bolster HeartSciences deal and private placement stake

Aug 20, 2026, 7:33 AM EDT1 sourcesAI-analyzed

Why it may matterVerify against the original reporting

Deal progress and Fortitude’s material HSCS stake could reduce funding risk and support a valuation re-rate for HSCS; similar past announcements often trigger initial upside on visibility, though closing risk remains.

AI summary

What happened, with direct paths to the underlying reporting

Fortitude Mining reported Q2 revenue of $20.9 million and Adjusted EBITDA of $8.5 million, mining ~33,646 ZEC at 4.0 GSol/s and expanding power to 60+ MW. It disclosed a private placement purchasing 411,522 HeartSciences shares at VWAP $2.43, giving Fortitude ~9.4% ownership as the companies pursue a H2 2026 closing of their business combination. The deal could accelerate HeartSciences' path to public markets and strengthen its balance sheet.

Q2 revenue $20.9M; Adjusted EBITDA $8.5M; ZEC mined ~33,646.
Hash rate 4.0 GSol/s; power portfolio 60+ MW across seven sites.
Fortitude bought $1.0M HeartSciences stock; private placement; closing H2 2026.
Proposed Fortitude-HeartSciences business combination expected to close in H2 2026.

How to read this signal

Transparent limits for an AI-generated research aid

StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.